Pharmacogenetics of the vitamin D receptor and osteoporosis

Drug Metabolism and Disposition

Volumn 29, Issue 4 II, 2001, Pages 505-512

  Eisman, J A ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; ESTROGEN RECEPTOR; PARATHYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR SP1; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ALLELE; BINDING SITE; BONE DENSITY; CALCIUM ABSORPTION; CALCIUM INTAKE; CHROMOSOME 11; CONFERENCE PAPER; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; LIFESTYLE; OSTEOPOROSIS; PHARMACOGENETICS; PRIORITY JOURNAL;

ALLELES; CALCIUM; DIET; HUMANS; OSTEOPOROSIS; PHARMACOGENETICS; RECEPTORS, CALCITRIOL; VARIATION (GENETICS);

EID: 0035059726     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (230)

1. Vitamin D receplor alleles do not correlate with bone mineral density in premenopausal Caucasian women from the southeastern United States
2. Vitamin D receptor gene Fok 1 polymorphism predicts calcium absorption and bone mineral density in children
3. A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women
4. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: A study of postmenopausal twins
5. Polymorphisms of the vitamin D receptor gene do not predict quantitative ultrasound of the calcaneus or hip axis length
6. Genetic influences on muscle strength, lean body mass and bone mineral density: A twin study
7. Vitamin D receptor gene polymorphism, bone mass, body size and vitamin D receptor density
8. Genetic variability in adult bone density among inbred strains of mice
9. Location of genes regulating volumetric bone density in C57BL/6J (low) and C3H/HeJ (high) inbred strains of mice
10. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene
11. Detection and confirmation of osteopenia-associated loci in two independent crosses between closely related mouse strains with differing bone densities
12. Risk factors for the development of osteoporosis in a South African population. A prospective analysis
13. Genotypes of the vitamin-D-receptor gene and bone mineral density in Caucasoid postmenopausal females
14. Mortality following fractures in older women. The study of osteoporotic fractures
15. Vitamin D receptor alleles b, a, and T: Risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1
16. Vitamin D receptor genotypes in primary hyperparathyroidism
17. Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism
18. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism
19. The epidemiology and pathogenesis of osteoporosis
20. Mortality after all major types of osteoporotic fracture in men and women: An observational study
21. Population-based study of survival after osteoporotic fractures
22. Secular trends in the incidence of postmenopausal vertebral fractures
23. Is caffeine consumption a risk factor for osteoporosis?
24. Vertebral fractures
25. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis
26. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts
27. Risk factors for hip fracture in white women
28. Sodium excretion influences calcium homeostasis in elderly men and women
29. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype
30. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
31. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q
32. The influence of family history of hip fracture on the risk of vertebral deformity in men and women: The European Vertebral Osteoporosis Study
33. Suggestive linkage of the parathyroid receptor type I to osteoporosis
34. Candidate gene linkage screen in osteoporosis
35. Vitamin D receptor 3'-untranslated region polymorphisms: Lack of effect on mRNA stability
36. Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: The OFELY study
37. Genetics of osteoporosis
38. Peak bone mass and osteoporosis prevention
39. The variable incidence of hip fracture in southern Europe: The MEDOS Study
40. Weight change and fractures in older women
41. Body size and hip fracture risk in older women: A prospective study
42. Vitamin D receptor gene polymorphisms and the risk of fractures in older women
43. Bone mass is low in relatives of osteoporotic patients
44. Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density
45. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: Interaction with age, dietary calcium and 3′-end region polymorphisms
46. Familial resemblance for bone mineral mass is expressed before puberty
47. Vitamin D receptor genotype and the risk of bone fractures in women
48. The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women
49. Determinants of hip axis length in women aged 10-89 years: A twin study
50. Vitamin D receptor gene polymorphism in men and its effect on bone density and calcium absorption
51. Genetic aspects of osteoporosis
52. Collagen Ialpha 1 Spl polymorphism, bone mass and bone turnover in healthy French premenopausal women: The OFELY study
53. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY Study
54. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women
55. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: Evidence of multiple gene contribution to bone mineral density
56. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women
57. The association of bone mineral density with vitamin D receptor gene polymorphisms
58. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype
59. Reduced bone density and osteoporosis associated with a polymorphic Spl binding site in the collagen type I alpha I gene
60. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women
61. Vitamin D receptor gene polymorphisms: Analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts
62. Segregation analysis and variance components analysis of bone mineral density in healthy families
63. World-wide projections for hip fracture
64. Lack of relationship between vitamin D receptor genotype and forearm bone gain in healthy children, adolescents, and young adults
65. Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women
66. Genetic and environmental correlations between bone formation and bone mineral density: A twin study
67. Weight, body composition, and bone density in postmenopausal women
68. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women
69. Vitamin D receptor gene polymorphism: Correlation with bone mineral density in a Brazilian population with insulin-dependent diabetes mellitus
70. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians
71. Genetic, common environment, and individual specific components of variance for bone mineral density in 10- to 26-year-old females: A twin study
72. Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: Studies in a UK population
73. Genetic influences on bone density: Physiological correlates of vitamin D receptor gene alleles in premenopausal women
74. Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: A twin study
75. Genetic influences on bone density: Physiological correlates of vitamin D receptor gene alleles in premenopausal women. Notification of genotype corrections
76. Influence of handedness on calcaneal ultrasound; Implications for assessment of osteoporosis and study design
77. The contribution of bone loss to postmenopausal osteoporosis
78. Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus
79. Calcium retention in relation to calcium intake and postmenarcheal age in adolescent females
80. Hospitalization with vertebral fracture among the aged: A national population-based study 1986-1989
81. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence
82. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)
83. Physical mapping and characterization of the high bone mass (HBM) gene region
84. Changes in skeletal tissue during the aging process
85. Determinants of peak bone mass
86. Peak bone mass, bone loss and risk of fracture
87. Calcium supplementation and increases in bone mineral density in children
88. Progressive loss of bone in the femoral neck in elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study
89. Symptomatic fracture incidence in elderly men and women: The Dubbo Osteoporosis Epidemiology Study (DOES)
90. Prevalent vertebral deformities: Relationship to bone mineral density and spinal osteophytosis in elderly men and women
91. Allelic variation in the vitamin D receptor, lifestyle factors and lumbar spinal degenerative disease
92. Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families
93. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia
94. Calcium requirements for optimal skeletal health in women
95. The incidence of hip fracture in Europe
96. Calcium nutrition and its implications for osteoporosis. Part 1. Children and healthy adults
97. Calcium nutrition and its implications for osteoporosis. Part II. After menopause
98. Osteoporosis: A view into the next century
99. Epidemiology of vertebral osteoporosis
100. Calcium supplementation of the diet
101. Polymorphisms of the vitamin D receptor, infant growth, and adult bone mass
102. Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene
103. A novel TGF-?I gene polymorphism is linked and associated with hip BMD in female twins
104. Allelic variation at the interleukin- I receptor antagonist gene is associated with early postmenopausal bone loss at the spine
105. Genetic factors in bone turnover
106. Genetic influences on bone turnover, bone density and fracture
107. Changes in axial bone density with age: A twin study
108. Dietary calcium, sex hormones, and bone mineral density in men
109. Sex differences in peak adult bone mineral density
110. Retired elite female ballet dancers and nonathletic controls have similar bone mineral density at weightbearing sites
111. Bone mineral density (BMD), hip fracture and apolipoprotein E (ApoE) genotype
112. The Bsm1 vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density
113. Effect of vitamin D receptor genotypes on calcium absorption, duodenal vitamin D receptor concentration, and serum 1,25 dihydroxyvitamin D levels in normal women
114. Association between intestinal vitamin D receptor, calcium absorption, and serum 1,25 dihydroxyvitamin D in normal young and elderly women
115. Association of bone mineral density with polymorphism of the estrogen receptor gene
116. Heritable and life-style determinants of bone mineral density
117. Soft tissue body composition: Familial resemblance and independent influences on bone mineral density
118. Vitamin D receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake
119. Dual-energy X-ray absorptiometry in normal women: A cross-sectional study of 717 Finnish volunteers
120. Bone mineral density and risk factors for osteoporosis: A population-based study of 1600 perimenopausal women
121. Insulin-like growth factor-1 in men with idiopathic osteoporosis
122. A sequence variation: 713-8delC in the transforming growth factor-beta I gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women
123. An Spl binding site polymorphism in the COLIAI gene predicts osteoporotic fractures in both men and women
124. Vitamin D receptor alleles and bone mineral density in a normal premenopausal Brazilian female population
125. Polymorphism at the SpI binding site in the collagen type I alpha I gene does not predict bone mineral density in postmenopausal women in Sweden
126. Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans
127. Epidemiology and predictors of fractures associated with osteoporosis
128. Effects of heredity, age, weight, puberty, activity, and calcium intake on bone mineral density in children
129. Lack of a high prevalence of the BB vitamin D receptor genotype in severely osteoporotic women
130. Osteoporosis risk factors in eighth grade students
131. Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women
132. Dietary salt, urinary calcium, and bone loss
133. Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women
134. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians
135. Familial comparison of bone mineral density at the proximal femur and lumbar spine
136. Prevalence and incidence of vertebral deformities
137. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women
138. Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: Lack of correspondence with common allelic variants
139. Prediction of bone density from vitamin D receptor alleles
140. Prediction of bone density from vitamin D receptor alleles
141. Contribution of trans-acting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphism and circulating osteocalcin
142. Polymorphisms of the interleukin-6 gene are associated with bone mineral density
143. Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans?
144. Vitamin D receptor genotypes are related to bone size and bone density in men
145. Bone mass, lean mass, and fat mass: Same genes or same environments?
146. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures
147. Vitamin D receptor genotypes in osteoporosis
148. Vitamin D receptor gene and osteoporosis
149. A case-control study of hip fracture: Evaluation of selected dietary variables and teenage physical activity
150. A genome-wide scan for loci linked to forearm bone mineral density
151. Calcium and osteoporosis
152. Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women
153. Gender differences in bone mass are genetically determined: Quantitative trait loci analyses
154. Axial bone mass in older women. Study of Osteoporotic Fractures Research Group
155. Bone density in osteogenesis imperfecta may well be normal
156. Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass
157. Effects of tobacco use on axial and appendicular bone mineral density
158. Estrogen receptor genotypes and bone mineral density in women and men
159. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women
160. Vitamin D receptor genotypes and changes of bone density in physically active German women with high calcium intake
161. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report front the National Osteoporosis Foundation
162. Bone gain in young adult women
163. Determinants of total body and regional bone mineral density in normal postmenopausal women: A key role for fat mass
164. Volumetric bone density of the lumbar spine is related to fat mass but not lean mass in normal postmenopausal women
165. Circulating insulin levels are related to bone density in normal postmenopausal women
166. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men
167. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women
168. Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up study
169. Assessing IGF-I dependent and independent loci that regulate femoral bone density by development of congenic little mice
170. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities
171. Insulin-like growth factors and bone: The osteoporosis connection revisited
172. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: Implications for genetic studies of bone mineral density
173. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent
174. The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women
175. Determinants of premenopausal bone mineral density: The interplay of genetic and lifestyle factors
176. Corticosteroid effects on proximal femur bone loss
177. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: A longitudinal study
178. Reduced bone density in women with fractures: Contribution of low peak bone density and rapid bone loss
179. The dilemma of osteoporosis in men
180. Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study
181. Reduced femoral neck bone density in the daughters of women with hip fractures: The role of low peak bone density in the pathogenesis of osteoporosis
182. Bone response to normal weight bearing after a period of skeletal unloading
183. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(1) chain of type I collagen
184. Association of bone mineral density with apolipoprotein E phenotype
185. Long-term bone loss in men: Effects of genetic and environmental factors
186. Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates
187. Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon absorptiometry
188. Bone mass and anthropometric measurements in adult females
189. High intensity activities in young women: Site specific bone mass effects among female figure skaters
190. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens
191. Role of physical activity in the development of skeletal mass in children
192. Influences on skeletal mineralization in children and adolescents: Evidence for varying effects of sexual maturation and physical activity
193. The genetics of proximal femur geometry, distribution of bone mass and bone mineral density
194. Family history of osteoporosis and bone mineral density at the axial skeleton: The Rancho Bernardo Study
195. Osteopenia as a feature of the androgen insensitivity syndrome
196. Familiality and partitioning the variability of femoral bone mineral density in women of child-bearing age
197. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: The Chingford Study
198. Osteopenia in 37 members of seven families: Analysis based on a model of dominant inheritance
199. Vitamin D receptor genotype is not associated with bone mineral density in three ethnic/regional groups
200. Mutation analysis of coding sequences for type I procollagen in individuals with low bone density
201. Mutation in a gene for type I proconagen (COL1A2) in a woman with postmenopausal osteoporosis: Evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta
202. Association between vitamin D receptor gene polymorphism and sex-dependent growth during the first two years of life
203. Correlation between vitamin D receptor genotypes and bone mineral density in Japanese patients with osteoporosis
204. Peak bone mass in young women
205. Genetic influences on type I collagen synthesis and degradation: Further evidence for genetic regulation of bone turnover
206. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women
207. Prediction of perimenopausal fractures by bone mineral density and other risk factors
208. Bone mineral density and bone markers in relation to vitamin D receptor gene polymorphisms in Chinese men and women
209. HLA-A*24-B*07-DRBI *01 haplotype implicated with genetic disposition of peak bone mass in healthy young Japanese women
210. Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women
211. Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women: The results of the baseline postal enquiry of the Kuopio osteoporosis risk factor and prevention study
212. Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee
213. Relation of alleles of the collagen type Ialphal gene to bone density and the risk of osteoporotic fractures in postmenopausal women
214. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density
215. Bone mineral density in mother-daughter pairs: Relations to lifetime exercise, lifetime milk consumption and calcium supplements
216. Influence of the vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women
217. Common polymorphism of the vitamin D receptor gene is associated with variation of peak bone mass in young Finns
218. Differences in calcium kinetics between adolescent girls and young women
219. Differences in calcium metabolism between adolescent and adult females
220. Calcium retention estimated from indicators of skeletal status in adolescent gifts and young women
221. Bone mineral density and its change in white women: Estrogen and vitamin D receptor genotypes and their interaction
222. Determinants of bone mineral density in postmenopausal white Iowans
223. Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene and calcium absorption in premenopausal women
224. Very low rates of hip fracture in Beijing, People's Republic of China the Beijing osteoporosis project
225. Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women
226. Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease
227. Determinants of bone mass in 10- to 26-year-old females: A twin study
228. Bone strength segregates in HcB/Dem recombinant congenic mouse strains
229. Vitamin D receptor gene polymorphisms, bone turnover and rates of bone loss in older African-American women
230. Recent progress in understanding the genetic susceptibility to osteoporosis